BioSyent, Inc. (RX.V)
17.15
+0.23
(+1.36%)
CAD |
TSXV |
Oct 09, 16:00
BioSyent Price : 17.15 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 16.92 | 17.15 | 16.70 | 17.15 | 2466.00 |
| Oct 08, 2026 | 16.62 | 16.92 | 16.62 | 16.92 | 2461.00 |
| Oct 07, 2026 | 16.62 | 16.90 | 16.62 | 16.90 | 1507.00 |
| Oct 06, 2026 | 16.61 | 16.90 | 16.61 | 16.80 | 711.00 |
| Oct 05, 2026 | 16.51 | 16.86 | 16.51 | 16.86 | 612.00 |
| Oct 02, 2026 | 16.26 | 16.74 | 16.21 | 16.73 | 3549.00 |
| Oct 01, 2026 | 16.53 | 16.53 | 16.50 | 16.50 | 1386.00 |
| Sep 30, 2026 | 17.00 | 17.00 | 16.70 | 16.70 | 1830.00 |
| Sep 29, 2026 | 16.78 | 16.78 | 16.78 | 16.78 | 219.00 |
| Sep 28, 2026 | 16.30 | 16.78 | 16.30 | 16.78 | 7582.00 |
| Sep 25, 2026 | 16.35 | 16.50 | 16.20 | 16.20 | 6290.00 |
| Sep 24, 2026 | 16.70 | 16.88 | 16.51 | 16.55 | 802.00 |
| Sep 23, 2026 | 17.46 | 17.46 | 16.33 | 16.54 | 6686.00 |
| Sep 22, 2026 | 16.14 | 17.50 | 16.13 | 17.49 | 22404.00 |
| Sep 21, 2026 | 15.80 | 16.09 | 15.80 | 16.00 | 3151.00 |
| Sep 18, 2026 | 16.18 | 16.18 | 15.73 | 15.73 | 427.00 |
| Sep 17, 2026 | 16.09 | 16.12 | 16.06 | 16.06 | 2673.00 |
| Sep 16, 2026 | 15.97 | 16.08 | 15.70 | 16.08 | 99233.00 |
| Sep 15, 2026 | 15.84 | 15.98 | 15.77 | 15.98 | 5000.00 |
| Sep 14, 2026 | 15.65 | 15.98 | 15.65 | 15.85 | 2046.00 |
| Sep 11, 2026 | 15.56 | 15.70 | 15.56 | 15.66 | 4555.00 |
| Sep 10, 2026 | 15.69 | 15.69 | 15.64 | 15.65 | 4430.00 |
| Sep 09, 2026 | 15.85 | 15.85 | 15.59 | 15.69 | 5326.00 |
| Sep 08, 2026 | 16.03 | 16.03 | 15.85 | 15.85 | 2240.00 |
| Sep 04, 2026 | 16.03 | 16.03 | 15.87 | 15.97 | 4234.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 4.09 |
| Bausch Health Cos., Inc. | 8.64 |
| Cipher Pharmaceuticals, Inc. | 13.65 |
| Revive Therapeutics Ltd. | 0.025 |
| Knight Therapeutics, Inc. | 10.83 |
Price Related Metrics
| PE Ratio | 20.01 |
| PS Ratio | 3.542 |
| PEG Ratio | 1.008 |
| Price to Book Value | 4.242 |
| Price to Free Cash Flow | 16.95 |
| Earnings Yield | 5.00% |
| Market Cap | 194.49M |
| PEGY Ratio | 0.9486 |
| Operating PE Ratio | 15.28 |
| Normalized PE Ratio | 20.01 |